GSK ready to build drug testing in EU as Brexit looms

LONDON (Reuters) - Britain's biggest drugmaker GlaxoSmithKline is moving ahead with Brexit contingency planning "right now", including preparing a system to test drugs in the European Union if Britain crashes out of the bloc without a trade deal.